Wellington Management Group LLP boosted its position in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 84.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 18,325,123 shares of the company’s stock after acquiring an additional 8,400,208 shares during the period. Wellington Management Group LLP owned 0.11% of Option Care Health worth $425,143,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of OPCH. Cornerstone Investment Partners LLC raised its stake in shares of Option Care Health by 3.6% during the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock worth $221,000 after acquiring an additional 333 shares in the last quarter. UMB Bank n.a. increased its position in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares in the last quarter. Assetmark Inc. lifted its holdings in shares of Option Care Health by 2.0% during the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock valued at $579,000 after purchasing an additional 487 shares during the last quarter. Pacer Advisors Inc. lifted its holdings in shares of Option Care Health by 2.2% during the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock valued at $591,000 after purchasing an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management boosted its position in shares of Option Care Health by 2.4% in the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock worth $553,000 after purchasing an additional 550 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on OPCH shares. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group initiated coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. JMP Securities restated a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Barrington Research lifted their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $33.00.
Insider Activity at Option Care Health
In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.64% of the stock is currently owned by insiders.
Option Care Health Stock Up 0.6 %
OPCH stock opened at $34.95 on Tuesday. The company has a market capitalization of $5.74 billion, a P/E ratio of 29.37, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The firm’s fifty day simple moving average is $32.58 and its 200-day simple moving average is $28.40. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.
Option Care Health Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Compound Interest and Why It Matters When Investing
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- The How And Why of Investing in Oil Stocks
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.